west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "许林" 3 results
  • 机械通气在胸部肿瘤术后急性呼吸衰竭治疗中的应用

    目的 总结胸部肿瘤患者术后发生急性呼吸衰竭(ARF)行机械通气治疗的经验。 方法 根据64例胸部肿瘤患者术后发生ARF的情况,如原发病、手术后的肺疾病、呼吸肌力和手术并发症等进行不同的机械通气治疗,其中61例进行有创通气治疗,3例进行无创性正压通气。对12例肺不张或严重肺部感染者进行床旁纤维支气管镜吸痰、支气管肺泡灌洗(BAL)。 结果 64例ARF中 54例治愈,10例死亡。12例肺不张或严重肺部感染者经纤维支气管镜治疗均有效;随访54例,随访时间2个月,无ARF复发。 结论 胸部肿瘤患者术后发生ARF应选择恰当的通气模式,进行个性化机械通气治疗,良好的机械通气有利于治疗术后并发症;对有肺不张或严重肺部感染者进行纤维支气管镜吸痰和BAL治疗效果良好。

    Release date:2016-08-30 06:09 Export PDF Favorites Scan
  • Clinical Analysis of 12 Patients Undergoing Robot-assisted Pulmonary Lobectomy

    ObjectiveTo investigate the safety and efficacy of robot-assisted pulmonary lobectomy using da Vinci S System, and explore its advantages in minimally invasive surgery. MethodsFrom May 2009 to May 2013, 12 patients with suspected non-small cell lung cancer (NSCLC) underwent robot-assisted lobectomy using da Vinci S System in Shanghai Chest Hospital. There were 6 male and 6 female patients with their age of 40-61 (52±8) years. Robotic instruments were used through a 12-mm observation port, two 8-mm thoracoscopic ports and a 12 to 40 mm utility incision without rib spreading. Perioperative data of the patients were collected and analyzed. ResultsAll the 12 patients successfully received surgical resection. All types of lobectomy were performed, and all the procedures were radical resection. Each patient received 4 to 9 (5±1) stations of lymph node dissection. None of the patients underwent conversion to thoracotomy. There was no perioperative mortality or morbidity in this group. Chest drainage duration was 3-11 (8±7) days. Length of hospital stay was 6 to 18 (14±8) days. Operation time was 60 to 280 (185±78) minutes. Intraoperative blood loss was 20 to 200 (108±71) ml. There was no perioperative blood transfusion. ConclusionsRobot-assisted lobectomy is initially proven a safe and effective procedure with enhanced visualization and better dexterity and stability than video-assisted thoracopscopic surgery. Thus surgical indications for robot-assisted lobectomy can be widened. Robot-assisted lobectomy is an important choice in the new age of minimally invasive thoracic surgery.

    Release date: Export PDF Favorites Scan
  • The 5-year survival rate of 11 958 postoperative non-small cell lung cancer patients in stage Ⅰ-ⅢA by two different follow-up patterns: A multi-center, real-world study

    ObjectiveTo compare the 5-year survival rates between two different follow-up patterns of postoperative stage Ⅰ-ⅢA non-small cell lung cancer (NSCLC) patients.MethodsPathological stage Ⅰ-ⅢA NSCLC 11 958 patients who underwent surgical resection and received follow-up within 6 months after initial diagnosis through telephone follow-up system were included in nine hospitals from July 2014 to July 2020. The patients were divided into two groups including a proactive follow-up group (n=3 825) and a passive follow-up group (n=8133) according to the way of following-up. There were 6 939 males and 5 019 females aged 59.8±9.5 years. The Kaplan-Meier and Cox proportional hazards regression model were used.ResultsThe median follow-up frequency was 8.0 times in the proactive follow-up group and 7.0 times in the passive follow-up group. The median call duration was 3.77 minutes in the proactive follow-up group and 3.58 minutes in the passive follow-up group. The 5-year survival rate was 81.8% and 74.2% (HR=0.60, 95CI 0.53-0.67, P<0.001) in the proactive follow-up group and the passive follow-up group, respectively. Multivariate analysis showed that follow-up pattern, age, gender and operation mode were independent prognostic factors, and the results were consistent in all subgroups stratified by clinical stages.ConclusionThe proactive follow-up leads to better overall survival for resected stage Ⅰ-ⅢA NSCLC patients, especially in the stage ⅢA.

    Release date:2021-07-02 05:22 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content